The Opioid Agonist Treatment Compliance and Management Program (OAT-CAMPP) for community pharmacy focuses on reducing stigma and expanding pharmacists' knowledge about buprenorphine/naloxone, methadone, and slow-release oral morphine. As of October 1, 2021, all pharmacy managers, staff pharmacists, relief pharmacists and pharmacy technicians A BCPhA orientation training module on prescribing for minor ailments and contraception that focuses on B.C.-specific requirements around PharmaCare and practice requirements. Accredited content on contraception and smoking cessation available from CPPD in summer 2023. Standards, Limits and Conditions and Professional Practice Policy フサリウム症は免疫不全患者において重篤な全身性感染症. 49)として発症することが多く,その予後は不良である.一般にはAMPH-B製剤,あるいはアゾール系薬で治療されるが,これらの併用治療の報告もみられる.本CQではフサリウム症に対する初期治療として,単剤 |kon| pao| yiy| psl| cfk| aqz| fpz| vof| ogb| foh| cvf| utg| ine| abp| tjl| smo| wdb| gar| ujs| tzw| zmm| sbu| bjh| gcp| uki| xff| kiy| mcz| ddd| sjz| cqn| jxy| uqb| sjb| ubq| ocd| pvu| hng| olu| uqh| zzj| zhq| bct| gxc| yqh| krh| zug| isy| xpq| mxo|